Jason Lettmann - Mar 14, 2025 Form 4 Insider Report for ALX ONCOLOGY HOLDINGS INC (ALXO)

Role
CHIEF EXECUTIVE OFFICER, Director
Signature
/s/ Shelly Pinto, by power of attorney
Stock symbol
ALXO
Transactions as of
Mar 14, 2025
Transactions value $
$0
Form type
4
Date filed
3/18/2025, 04:41 PM
Previous filing
Feb 21, 2025
Next filing
Apr 15, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALXO Common Stock Award $0 +42K +24.67% $0.00 212K Mar 14, 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported shares are represented by performance share units, or PSUs, and were awarded upon the achievement of certain performance metrics related to the positive results for ASPEN-06 clinical trials. Shares subject to the PSU vest on March 14, 2026.